Log in to save to my catalogue

Amniotic mesenchymal cells from pre‐eclamptic placentae maintain immunomodulatory features as health...

Amniotic mesenchymal cells from pre‐eclamptic placentae maintain immunomodulatory features as health...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4717851

Amniotic mesenchymal cells from pre‐eclamptic placentae maintain immunomodulatory features as healthy controls

About this item

Full title

Amniotic mesenchymal cells from pre‐eclamptic placentae maintain immunomodulatory features as healthy controls

Publisher

England: John Wiley & Sons, Inc

Journal title

Journal of cellular and molecular medicine, 2016-01, Vol.20 (1), p.157-169

Language

English

Formats

Publication information

Publisher

England: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Pre‐eclampsia (PE) is one of the most severe syndromes in human pregnancy, and the underlying mechanisms of PE have yet to be determined. Pre‐eclampsia is characterized by the alteration of the immune system's activation status, an increase in inflammatory Th1/Th17/APC cells, and a decrease in Th2/Treg subsets/cytokines. Moreover, inflammatory infi...

Alternative Titles

Full title

Amniotic mesenchymal cells from pre‐eclamptic placentae maintain immunomodulatory features as healthy controls

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4717851

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4717851

Other Identifiers

ISSN

1582-1838

E-ISSN

1582-4934

DOI

10.1111/jcmm.12715

How to access this item